The specificity of the FOXL2 c.402C>G somatic mutation: A survey of solid tumors

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Schrader, Kasmintan A ^a,b   Gorbatcheva, Bella ^c   Senz, Janine ^a,b   Heravi Moussavi, Alireza ^a   Melnyk, Nataliya ^a,b   Salamanca, Clara ^a   Maines Bandiera, Sarah ^a   Cooke, Susanna L ^d   Leung, Peter ^e   Brenton, James D ^d   Gilks, C Blake ^f   Monahan, John ^b   Huntsman, David G ^a,c,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^d Cambridge Research Institute   (United Kingdom)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG; CYSTEINE; FORKHEAD TRANSCRIPTION FACTOR; FOXL2 PROTEIN, HUMAN; TRYPTOPHAN;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; DNA SCREENING; GENE AMPLIFICATION; GRANULOSA CELL TUMOR; HUMAN; KARYOTYPE; NUCLEOTIDE SEQUENCE; OVARY CANCER; POLYMERASE CHAIN REACTION; SOLID TUMOR; SOMATIC MUTATION; ALLELE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; GENOMICS; KARYOTYPING; METABOLISM; MUTATION; OVARY TUMOR; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ALLELES; CELL LINE, TUMOR; CYSTEINE; CYTOGENETICS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENOMICS; GRANULOSA CELL TUMOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MUTATION; OVARIAN NEOPLASMS; TISSUE DISTRIBUTION; TRYPTOPHAN;

EID: 71049147592     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007988     Document Type: Article

References (15)

1. Koukourakis GV, Kouloulias VE, Koukourakis MJ, Zacharias GA, Papadimitriou C, et al. (2008) Granulosa cell tumor of the ovary: Tumor review. Integr Cancer Ther 7(3): 204-215.
2. Shah SP, Kobel M, Senz J, Morin RD, Clarke BA, et al. (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med.
3. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, et al. (2004) The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131(4): 933-942.
4. Kalfa N, Fellous M, Boizet-Bonhoure B, Patte C, Duvillard P, et al. (2008) Aberrant expression of ovary determining gene FOXL2 in the testis and juvenile granulosa cell tumor in children. J Urol 180(4 Suppl): 1810-1813.
5. Nishi Y, Yanase T, Mu Y, Oba K, Ichino I, et al. (2001) Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142(1): 437-445.
6. Reed GH, Wittwer CT (2004) Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 50(10): 1748-1754.
7. Herrmann MG, Durtschi JD, Wittwer CT, Voelkerding KV (2007) Expanded instrument comparison of amplicon DNA melting analysis for mutation scanning and genotyping. Clin Chem 53(8): 1544-1548.
8. Lie BL, Leung E, Leung PC, Auersperg N (1996) Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol 120(2): 169-176.
9. Mayr D, Hirschmann A, Marlow S, Horvath C, Diebold J (2008) Analysis of selected oncogenes (AKT1, FOS, BCL2L2, TGFbeta) on chromosome 14 in granulosa cell tumors (GCTs): A comprehensive study on 30 GCTs combining comparative genomic hybridization (CGH) and fluorescence-in situ-hybridization (FISH). Pathol Res Pract 204(11): 823-830.
10. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al. (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27(2): 159-166.
11. Beysen D, De Jaegere S, Amor D, Bouchard P, Christin-Maitre S, et al. (2008) Identification of 34 novel and 56 known FOXL2 mutations in patients with Blepharophimosis syndrome. Hum Mutat 29(11): E205-19.
12. Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA (2007) Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci U S A 104(9): 3330-3335.
13. Benayoun BA, Batista F, Auer J, Dipietromaria A, L'Hote D, et al. (2009) Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: Evidence for a regulatory imbalance induced by disease-causing mutations. Hum Mol Genet 18(4): 632-644.
14. Beysen D, Moumne L, Veitia R, Peters H, Leroy BP, et al. (2008) Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation. Hum Mol Genet 17(13): 2030-2038.
15. Moumne L, Dipietromaria A, Batista F, Kocer A, Fellous M, et al. (2008) Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. Hum Mol Genet 17(7): 1010-1019.